Our study shows that, in a population of high-risk PCa undergoing surgery, the strongest independent prognostic factors of disease progression were PLNI, which was clinically predicted by well-validated prognostic factors including PSA > 20 ng/mL, adverse tumor stage (cT2/3) and grade (ISUP 4/5). This evidence concerns the gene KLK3 and neoplasm.